Accumulation of unfolded proteins triggers endoplasmic reticulum (ER) stress and is considered a part of the cellular responses to hypoxia. The nascent polypeptide-associated complex (NAC) participates in the proper maturation of newly synthesized proteins. However, thus far, there have been no comprehensive studies on NAC involvement in hypoxic stress. Here, we show that hypoxia activates glycogen synthase kinase-3b (GSK-3b) and that the activated GSK-3b destabilizes aNAC with the subsequent apoptosis of the cell. Hypoxia of various cell types and the mouse ischemic brain was associated with rapid downregulation of aNAC and ER stress responses involving PERK, ATF4, c-taxilin, elF2a, Bip, and CHOP. Depletion of aNAC by RNA interference specifically activated ER stress responses and caused mitochondrial dysfunction, which resulted in apoptosis through caspase activation. Interestingly, we found that the hypoxic conditions activated GSK-3b, and that GSK-3b inhibition prevented aNAC protein downregulation in hypoxic cells and rescued the cells from apoptosis. In addition, aNAC overexpression increased the viability of hypoxic cells. Taken together, these results suggest that aNAC degradation triggers ER stress responses and initiates apoptotic processes in hypoxic cells, and that GSK-3b may participate upstream in this mechanism.
The endoplasmic reticulum (ER) is the principal organelle that ensures correct control of protein folding and assembly. The perturbations that alter ER homeostasis can lead to the accumulation of unfolded proteins (UPs). To cope with this stress, cells activate an intracellular signaling pathway, the unfolded protein response (UPR). The UPR transmits information on the status of protein folding in the ER lumen to the cytoplasm and nucleus. 1 Cells that fail to restore a proper ER homeostasis are eventually eliminated by ER stress-induced, programed cell death. 2 Eukaryotic cells also use sophisticated mechanism to ensure the proper folding and targeting of newly synthesized proteins. The nascent polypeptide-associated complex (NAC) is the first non-ribosomal protein that the growing nascent chains (NCs) encounter. In addition to protecting the growing NCs on the ribosome from premature encounters, the NAC may also contribute to the inhibition of ribosomal binding to the ER membrane, and cotranslational protein import into the mitochondria. 3, 4 The cellular function of NAC appears to be diverse, and it is not restricted to translation. Prolonged ER stress is linked to the pathogenesis of several different neurodegenerative disorders. For example, the intracellular levels of the NAC subunits change dramatically in several human diseases such as Alzheimer's disease (AD) and malignant brain tumors. 5, 6 ER stress has also been observed following cerebral ischemia and reperfusion. Recently, bNAC was found to be a critical determinant of developmentally programed cell death of C. elegans. 7 Several publications have implicated the role of the NAC complex in apoptosis, but there is little information as to the pathways involved. The physiological significance of the cellular function of NAC has been determined in several studies using yeast, Drosophila, and mice. [8] [9] [10] Perturbation of ER functions with the resultant induction of ER stress responses may occur under various conditions such as hypoxia. 11 UPR is activated in tumor cells that are propagated in a poorly vascularized environment. Tumor cells are susceptible to nutrient starvation and hypoxic conditions that are prevalent in such an environment. However, tumor cells that survive the hypoxic conditions (hypoxic cells) confer radiotherapy and chemotherapy resistance, and also contribute to the selection of a more malignant phenotype, such as a metastatic phenotype. 12, 13 Therefore, resistance to hypoxia is a crucial factor for determining solid tumor progression and treatment efficacy. However, the involvement of aNAC in hypoxia-induced ER stress responses still remains to be explored.
In this study, we show that hypoxia downregulates aNAC but not bNAC. We found that aNAC downregulation in hypoxic cells or aNAC ablation by aNAC short-interfering RNA (siRNA) leads to the initiation of ER stress responses, which results in caspase-dependent apoptosis. Maintaining aNAC protein levels by inhibiting glycogen synthase kinase-3b (GSK-3b) or overexpression of aNAC reversed these effects in hypoxic cells. These results suggest that aNAC downregulation is a key initiator of hypoxia-induced apoptosis.
Results
Hypoxia induces aNAC downregulation. To test the possible involvement of aNAC in hypoxia-induced apoptosis, we examined whether the hypoxic condition could affect the levels of aNAC protein expression in HeLa S3 cells (Figure 1a-e) . HeLa S3 cells cultured under hypoxic conditions exhibited gradual decreases in the aNAC protein levels, which was evident at 4 h after the hypoxic treatment and reached levels less than 20% of the controls by 24 h. Annexin-positive apoptotic cells were not observed within 16 h after the treatment, indicating that the aNAC downregulation preceded the appearance of apoptotic phenotype (Figure 1c and d) . Importantly, hypoxia-induced aNAC downregulation is caspase-independent (Figure 1e ).
Hypoxia-induced aNAC downregulation was also observed in other cell types such as SH-SY5Y neuroblastoma cells (Figure 1f-i) . The apoptotic changes were evident 16 h after the initiation of cell culture under hypoxic conditions. The hypoxia-induced aNAC downregulation preceded (8 h after the initiation of hypoxic stress) the appearance of the apoptotic phenotype. In contrast, bNAC (b 1 NAC and b 2 NAC) expression was not significantly affected by hypoxia (Figure 1f ). These results are consistent with the notion that the integrity of bNAC is not dependent on the presence of aNAC. The hypoxic state also occurs in brain ischemia. Therefore, we examined mouse brains after temporary (2 h) occlusion of the right middle cerebral artery. 14 We assessed the ischemic mouse brain 22 h after the reperfusion. In the contralateral non-ischemic brains, aNAC was expressed in almost all the neurons (Figure 2 ). However, except for strong staining in some neuronal cells, aNAC expression was barely detected in the ischemic side of the striatum. Western blot analysis using homogenates obtained separately from the ischemic and contralateral hemispheres showed that aNAC expression was greatly decreased in the ischemic hemisphere; the incomplete suppression in aNAC expression may be because of the use of homogenates from the whole ischemic hemisphere, which comprises not just heavily damaged regions such as the striatum, but also the less damaged cortex, in which aNAC staining persists at this time point (Figure 2b ). Therefore, these results suggest that aNAC depletion is not solely a response in hypoxic HeLa S3 cells. As in the case of the hypoxic SH-SY5Y cells, bNAC expression was not affected by the ischemic assault (Figure 2b ). aNAC downregulation is sufficient for the induction of apoptosis. Next, we asked whether aNAC downregulation is sufficient to trigger apoptosis in cells cultured under nonhypoxic conditions. To this end, we depleted aNAC by RNA interference (Figure 3a-e) . The aNAC ablation by specific siRNA caused apoptosis as evident by Annexin (Figure 3d ) and Tunel (Figure 3e ) assays. The appearance of apoptotic nuclear phenotype was restricted to the cells with decreased aNAC protein, suggesting the specificity of the apoptotic effects exerted by aNAC depletion (Figure 3c) . A different aNAC siRNA oligonucleotide with a lower inhibitory effect on aNAC expression displayed proportionally lower apoptosisinducing activity, indicating a dose-response relationship between aNAC downregulation and the apoptotic phenotype (Supplementary Figure S1) . aNAC depletion initiates ER stress. Endoplasmic reticulum dysfunction has been postulated as a common pathologic denominator underlying acute and chronic neurodegenerative disorders, including brain ischemia. 15, 16 Therefore, we wished to test the hypothesis that aNAC depletion might lead to the activation of the UPR in the ER.
Endoplasmic reticulum stress signaling pathways involve three distinct stress sensor proteins (PERK, IRE1, and ATF6). 17 Bip is the master regulator of these three sensor proteins. Therefore, we first monitored the expression levels of Bip in aNAC-depleted HeLa S3 cells. We found that the Bip levels were elevated 72 h after the initiation of the siRNA treatment (Figure 4a ). The dissociation of Bip from PERK leads to autophosphorylation of PERK, which in return phosphorylates elF2a and then activates ATF4 translation. ATF4 increases the expression of proapoptotic factor CHOP. We found that aNAC ablation by RNA interference activated the phosphorylation of PERK and elF2a in HeLa S3 cells (Figure 4a ). These changes were first evident at 48 h after the initial addition of the siRNA and persisted at least in the following 24 h. On the other hand, the upregulation of CHOP expression was transient and the expression levels returned to those of the controls 72 h after the initial addition of the siRNA. aNAC ablation by siRNA interference did not significantly affect the bNAC protein levels (Figure 4a ). Similar changes were observed in the mouse ischemic brain ( Figure 2 ) and in the hypoxic SK-N-SH cells (Supplementary Figure S2) .
We also found that in the aNAC-depleted cells, ATF4 protein levels were slightly increased. Previous reports have shown that g-taxilin is a regulator of ATF4 activity and interacts with aNAC.
18,19 Therefore, we assessed g-taxilin protein . 20 On the other hand, the dissociation of Bip from ATF6 permits the translocation of ATF6 into the Golgi compartment for intramembrane proteolysis. However, we did not observe significant changes in the levels of phosphorylated JNK 21 or any product of the spliced XBP1 mRNA 22 (Supplementary Figure S3) . In addition, the expression of cleaved ATF6 was not observed in HeLa S3 cells. Taken together, these results suggest that the aNAC depletion-induced ER stress response occurred chiefly, if not exclusively, through the PERK-elF2a sensor pathway.
Ubiquitin accumulation in aNAC-depleted cells. Unfolded or misfolded proteins that are not transported from the ER to the Golgi compartment may be degraded by the ubiquitin/ proteasome pathway. 15 If this phenomenon occurs in aNACdepleted cells, ubiquitin must accumulate in the cytoplasm to degrade the unfolded or misfolded proteins. 23 Therefore, we tested this possibility by the immunohistochemical detection of ubiquitin localization in aNAC-depleted cells. Ubiquitin was aNAC depletion activates the mitochondrial apoptotic pathway. Endoplasmic reticulum stress with resultant ER dysfunction may initiate an apoptotic pathway involving cytochrome c release from the mitochondria. 16 In the control siRNA-treated cells, cytochrome c displayed punctate distribution throughout the cytoplasm (Figure 5a ) and was not detected in the cytoplasmic fraction of the cell lysates (Figure 5b ). However, in the aNAC siRNA-treated cells, cytochrome c lost its characteristic punctate staining pattern (Figure 5a ), and some amount of cytochrome c shifted from the mitochondrial to the cytoplasmic fraction (Figure 5b ).
The apoptotic cross-talk between the ER and the mitochondria requires calcium signaling from the ER to the mitochondria, which is inhibited by Bcl-2 and promoted by Bax. 16 Bcl-2 is degraded during the process of cell death. 24 Therefore, our next step involved the assessment of these signaling events. After aNAC depletion, the Bcl-2 protein expression was inhibited (Figure 5c ). In contrast, the Bax protein expression was increased. Mock treatment or treatment using the control siRNA did not significantly affect the expression of these proteins.
The mitochondrial apoptotic pathway involves the activation of caspase-9. 25 The involvement of caspase-4 and caspase-12 has been suggested, but their role in ER stress-induced apoptosis in humans remains controversial. 26 Therefore, to confirm the involvement of the caspase pathway in aNAC depletion-induced apoptosis, we monitored caspase-9 activation. We found that caspase-9 activation was correlated with Bcl-2 downregulation and Bax upregulation in aNACtreated HeLa S3 cells (Figure 5c ). Caspase-4 activation was not observed (Supplementary Figure S3) . The involvement of caspase family members in aNAC depletion-induced apoptosis was confirmed with the use of the pan-caspase inhibitor Z-VAD-FMK; this inhibitor greatly reduced the number of annexin-positive cells that were treated by the aNAC siRNA (Figure 5d ). These results suggest the possibility that the Bcl-2 downregulation in the aNAC-depleted cells may occur as a result of caspase-dependent degradation of Bcl-2 protein. Indeed, Bcl-2 is a well-known caspase substrate. However, we found that aNAC siRNA-induced Bcl-2 downregulation still occurred in the presence of Z-VAD-FMK, while Z-VAD-FMK effectively inhibited degradation of caspase-9, a well-known caspase substrate (Figure 5e ). A steady intracellular level of aNAC rescues hypoxic cells from apoptosis. These results collectively suggest that aNAC depletion can initiate apoptotic processes in hypoxic cells. Therefore, we hypothesized that if aNAC in hypoxic cells is prevented from degradation, the hypoxic cells could be rescued from apoptosis. GSK-3b is a serine/ threonine protein kinase that regulates a diverse array of cell functions, including signaling by insulin, growth factors, and nutrients, cell fate determination during embryonic development, control of cell division, and microtubule function. 27 A recent study has shown that GSK-3b can phosphorylate aNAC and that the GSK-3b-dependent phosphorylation of aNAC stimulated aNAC degradation. 28 Therefore, we tested the possibility that the prevention of aNAC degradation by the inhibition of GSK-3b might rescue the hypoxic cells from apoptosis. We found that GSK-3b activation and aNAC degradation coincided in hypoxic SK-N-SH cells (Figure 6a ). Lithium is a dual inhibitor of GSK-3, reducing the activity directly and also by increasing the inhibitory phosphorylation of GSK-3. [29] [30] [31] Indeed, lithium ions inhibited the dephosphorylation of GSK-3b and, interestingly, concomitantly inhibited the downregulation of aNAC in hypoxic SK-N-SH cells (Figure 6b ). More importantly, lithium ions dramatically rescued the hypoxia-induced apoptosis of SK-N-SH cells (Figure 6c-e) . The antiapoptotic effects were depended on the lithium ion concentration (Figure 6e) . A less effective inhibitor indirubin was proportionally less effective in rescuing the hypoxic cells (Figure 6b and d) . A third GSK-3b inhibitor, CHIR 99021, which is structurally different from the other two inhibitors, greatly inhibited the downregulation of aNAC in hypoxic cells and improved the viability (Figure 6b and d) . We obtained similar results with HeLa S3 cells (Supplementary Figure S4) .
Phosphorylation by p38 MAPK was proposed as an alternative pathway for GSK-3b inactivation. 32 Arai et al.
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demonstrated that ERK signaling pathway is involved in ER stress responses. Therefore, we also tested inhibitors against p38 MAPK and ERK. However, these were ineffective with regard to the recovery of aNAC from degradation or apoptosis under hypoxic conditions (Supplementary Figure S5) , which is suggestive of the specific function of GSK-3b in aNAC To support the notion that maintaining the intracellular levels of aNAC can prevent hypoxic cells from apoptosis, we transfected wild-type aNAC into HeLa S3 cells and then cultured the cells under hypoxic conditions. The aNAC transfection exerted mild effects on the viability of hypoxic cells, resulting in a significantly higher cell viability and lower incidence of apoptosis than the cells transfected with the vector alone (Figure 6f) . Collectively, these results suggest that aNAC degradation triggers ER stress responses and initiates apoptotic processes in hypoxic cells and that GSK-3b may participate upstream in this mechanism.
Discussion
In this report, we have presented evidence for the hypoxiainduced GSK-3b activation and the subsequent destabilization of aNAC. aNAC depletion resulted in the activation of ER stress signaling, cytochrome c release from the mitochondria, and caspase-dependent apoptosis. In hypoxic cells, aNAC downregulation occurred before the activation of ER stress signaling and the subsequent apoptotic events. More importantly, the prevention of aNAC degradation by GSK-3b inhibition or aNAC overexpression in hypoxic cells rescued the cells from apoptosis.
Several studies have implicated the role of the NAC complex in apoptosis. In particular, Bloss et al. 7 suggested the protective role of bNAC against cell apoptosis in C. elegans; bNAC inhibits the apoptosis of cells that are normally programed to die. Consistent with this, aNAC in yeasts lacking bNAC rendered the cells heat-sensitive. 10 bNAC downregulation was associated with apoptosis in human cells. 34 These results suggest that the bNAC may function as an antiapoptotic factor. However, the physiological significance of aNAC in the cell death mechanism has not been well elucidated. This study demonstrates that aNAC downregulation per se can lead to cell apoptosis through the ER stress mechanism in the presence of bNAC. A possible but not investigated explanation is that the loss of aNAC might induce the unregulated activities of the other members of the nascent chain-ribosome complexes, including bNAC. Beatrix et al. 35 showed that bNAC alone is sufficient to prevent ribosome binding to the ER. Therefore, bNAC may not be a component of the ER-targeted ribosome-nascent chain complexes. However, in the present experiment system, we could not determine whether the deletion of aNAC alone from the ribosome-nascent chain complexes leads to concomitant dissociation of the bNAC subunit from the complex. Further in vitro studies may be required to answer this question.
Apparently, the NAC complexes can bind to nascent polypeptide chains, and the vast majority of a and b NAC subunits are involved in the complex formation. 35 However, there might be individual functions for aNAC, bNAC, and the NAC complex in vivo. 36 For example, bNAC binds to ribosomes, but aNAC does not. 10, 35 Furthermore, mouse aNAC can be active as a transcriptional coactivator, but it loses its activity when bNAC is coexpressed. 37 Activation of JNK occurs in response to ER stress. 20 Moreover, an apoptosis signal-regulating kinase (ASK1) is required for TNF receptor-associated factor 2 (TRAF2)-dependent JNK activation during TNF-induced apoptosis.
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ASK1-deficient cells are resistant to ER stress-induced apoptosis, indicating that the TRAF2/ASK signaling pathway is critical for ER stress-induced apoptosis. 38 In addition, the interaction between aNAC and the Fas-associated death domain, which is a critical mediator of the TNF receptormediated signal-transduction pathway, is disrupted in response to TNF. 39 These results collectively suggest the complementary role of aNAC degradation in c-Jun-mediated apoptosis. However, JNK activation was not detected in aNAC-depleted cells, suggesting minimal if no contribution of the JNK pathway to the aNAC-dependent apoptosis.
Phosphorylated eIF2a inhibits translation by reducing the formation of translation initiation complex. 1 It is known that after 24 h of hypoxia in cell cultures a general shut-down in translation is induced. 40 Phosphorylated eIF2a also induces apoptosis by activating the ATF4-CHOP pathway. On the other hand, a recent study suggested that aNAC might function as a transcriptional coactivator. 37 Furthermore, aNAC was reported to interact with g-taxilin, which inhibits ATF4-mediated transcription. 18, 19 In this study, we showed that aNAC ablation by the RNA interference resulted in the upregulation of ATF4 and downregulation of g-taxilin (Figure 4a) , consistent with the previous findings. Therefore, these studies imply that aNAC and eIF2a might coordinately regulate transcriptional and translational responses of the cell to hypoxia, thereby determining the fate of the hypoxic cell. Recent studies have suggested that neuronal cell death in AD and ischemia could arise from dysfunction of the ER. 16 Specific downregulation of aNAC was observed in the brains of patients with AD and Down's syndrome with AD-like neuropathology. 5 The UPR program is activated to cope with the accumulation of unfolded or misfolded proteins in the ER. 1 The main role of the UPR is to restore ER function by reducing the load of proteins that are required to be folded and processed in the ER lumen and by increasing the protein folding and processing capacity. 16 If ER function cannot be restored, cells undergo apoptosis. Therefore, it is plausible that UPR is unable to rescue cells with severe aNAC depletion, as shown in the hypoxic cells and ischemic mouse brains. Along with these results, this notion implies that the aNAC depletion event might occur before ER stress in neuronal cells of ischemic brains.
However, the precise mechanism by which the hypoxic signals trigger the downregulation of aNAC has not been defined. The human aNAC contains a ubiquitin-associated (UBA) domain at its C terminus, but bNAC does not. 41 In addition, the Saccharomyces cerevisiae NAC complex (EGD), which consists of Egd1p (bNAC) and Egd2p (aNAC), can be ubiquitinated in vitro through a UBA domain at the C terminus of the Egd2p. 42 In hypoxic cells, aNAC but not bNAC might be degraded through the ubiquitin-protease system (UBS). However, cells undergoing ER stress may exhibit general inhibition of the UBS due to the presence of aberrant ubiquitin.
2 Therefore, in the later stages of the hypoxic cells and ischemic neurons, the ER stress may further degrade NAC due to impaired UBS activity.
Activation of the phosphatidylinositol-3-kinase (PI3-k)/ protein kinase B (AKT) pathway is associated with hypoxia. 43 The involvement of GSK-3b has been reported in hypoxia. 44 In addition, PI3-k/AKT inhibits GSK-3b by phosphorylating at the N terminus Ser 9. 45 Therefore, another possible and specific mediator of aNAC degradation could be GSK-3b; aNAC is a target for degradation by the 26S proteasome, which is regulated by GSK3b-dependent phosphorylation. 28 Indeed, this study demonstrated that hypoxic stress was associated with dephosphorylation of GSK-3b and that the inhibition of GSK-3b by lithium ions prevented dephosphorylation of GSK-3b and downregulation of aNAC, which rescued the hypoxic cells from apoptosis ( Figure 6 ). GSK-3b phosphorylates proteins at serine or threonine residues that are located 4 amino acids N-terminal to another phosphoserine (priming phosphorylation), which is introduced by other protein kinases. 31 The protein kinases that could introduce this priming phosphoserine vary depending on the substrates, and GSK-3b and casein kinase II may be the candidates for aNAC. 46 However, at present, the aNAC protein does not fulfill all the requirements as a physiological substrate for GSK-3b. 27, 28 Further studies are required for determining whether aNAC is a target of GSK-3b. Notwithstanding these facts, the phosphorylation-dependent aNAC downregulation and the subsequent induction of ER stress are intriguing with regard to understanding the mechanisms for the initiation of ER stress-induced apoptosis in hypoxia.
In this study, we did not find definitive evidence that MAP kinases are involved in the downregulation of aNAC in hypoxic cells. A previous study has shown that ERK MAP kinase is involved in the ER stress responses of thapsigargin-induced SH-SY5Y cells. 33 However, the ERK pathway activated by thapsigargin was found to lead to a non-caspase-dependent cell death. Therefore, the detailed upstream regulatory mechanism of aNAC degradation in hypoxia remains to be clarified in future studies.
In conclusion, we have defined the ER stress responses that are initiated by aNAC depletion in mammalian cells. We postulate that this ER stress-response pathway may be involved in the apoptotic mechanism in hypoxic cells.
Materials and Methods
Cell culture and hypoxia treatment. HeLa S3 human cervical cancer cells were cultured in DMEM supplemented with 10% FBS. SH-SY5Y and SK-N-SH human neuroblastoma cells were both grown in a-MEM supplemented with 10% FBS. The cells were cultured under hypoxic conditions (o1% pO 2 and 5% pCO 2 ) using an anaerobic culture kit (Mitsubishi Gas Chemicals, Tokyo, Japan). The system provides a hypoxic condition without affecting the pH of the medium. Z-VAD-FMK (BD PharMingen, Franklin Lakes, NJ, USA) was used as a pancaspase inhibitor.
RNA interference. Oligonucleotides corresponding to human aNAC (5 0 -CCAGUCAGUAAAGCAAAACTT) were transfected 1-3 times at 24-h intervals into HeLa S3 cells using Oligofectamine (Invitrogen, Carlsbad, CA, USA) or Lipofectamine RNAiMax (Invitrogen) according to the manufacturer's instructions. The effect of siRNA was measured 24-96 h after the first transfection. Luciferase GL2 siRNA (Qiagen) or AllStar Negative Control siRNA (Qiagen, Hilden, Germany) was used as a control.
Immunofluorescence microscopy. Cells were washed with PBS and fixed with 4% paraformaldehyde in PBS for 20 min, the cells were then permeabilized with 0.2% Triton X-100 in PBS for 15 min at room temperature. Blocking was performed with 1.5% BSA and 1.5% skim milk in PBS for 1 h at room temperature. Incubation with the primary antibody was performed overnight at 41C. Visualization of the nuclei was achieved by incubating the cells with DAPI (1 mg/ml) for 10 min at room temperature. Immunofluorescent visualization was carried out under a TCS SP2 AOBS confocal microscope (Leica, Mannheim, Germany).
Cell fractionation and Western blotting. Cells were collected and washed in ice-cold PBS, and fractionated into mitochondrial and cytosolic fractions using a Mitochondria Isolation Kit (PIERCE, Rockford, IL, USA). After centrifugation at 12 000 Â g for 15 min, the supernatants were pooled as the cytosolic fraction and the pellet for the mitochondrial fraction. The cytosolic fraction was concentrated by trichloroacetic acid precipitation. Equal amounts of proteins were then analyzed on a 15% polyacrylamide gel.
Antibodies. The antibodies used in this study were as follows: ATF4 (Santa Cruz, Santa Cruz, CA, USA), ATF6 (IMGENEX, San Diego, CA, USA), BIP (KDEL; Stressgen, Ann Arbor, MI, USA), Bcl-2 (Santa Cruz), Bax (Santa Cruz), cytochrome c (BD PharMingen, Danvers, MA, USA), CHOP (GADD 153; Santa Cruz), PERK (Cell Signaling Technology, Danvers, MA, USA), phospho-PERK (Santa Cruz), caspase-4 (Stressgen), cleaved caspase-9 (Cell Signaling Technology), ubiquitin (Cell Signaling Technology or BIOMOL, Plymouth Meeting, PA, USA), elF2a (Cell Signaling Technology), phospho-elF2a (Cell Signaling Technology), GSK-3b (Cell Signaling Technology), phospho-GSK-3b (Ser 9) (Cell Signaling Technology), EGFP (Clontech, Mountain View, CA, USA), phospho-JNK (Cell Signaling Technology), g-taxilin (Santa Cruz), XBP-1 (Santa Cruz), and b-actin (Santa Cruz). The antibodies against aNAC and bNAC were described previously. 4 GSK-3b, ERK, and p38 MAPK inhibition and aNAC transfection. Lithium chloride (Sigma, St Louis, MO, USA), CHIR 99021 (STEMGENT, Cambridge, MA, USA), and 5-iodo-indirubin-3 0 -monoxime (Calbiochem, San Diego, CA, USA) were used as pharmacological inhibitors of GSK-3 b. UO126 (Calbiochem) and SB 202190 (Calbiochem) were used for the inhibition of ERK and p38 MAPK, respectively. HeLa S3 cells were transfected with pEGFP-N2 vector (Clontech) containing the full-length aNAC using Effecten Transfection Reagent (Qiagen).
Assessment of apoptosis and cell viability. The TUNEL assay was performed using an in situ Cell Death Detection Kit TMR Red (Roche, Basel, Schweiz, Switzerland) according to the manufacturer's protocol. Apoptosis was also assessed after incubating cells with Annexin V-FITC (Sigma), or Annexin V-Cy3 (Sigma) at room temperature for 10 min. Cells positive for TUNEL or Annexin were analyzed by FACS scan. Cell viability was measured by a modified MTT dye reduction assay using WST-8 (2-(2-methoxy-4-nitrophenyl)-3-(4-nitrophenyl)-5-(2,4-disulfophenyl)-2H-tetrazolium, monosodium salt) (Dojindo Molecular Technologies, Kumamoto, Japan). Fraction viable cells represent the ratio of WST-8 values obtained from treated cells relative to untreated cells.
Mouse stroke model and immunohostochemistry. The experiments using mice were performed following an institutionally approved protocol in accordance with the National Institute of Health Guide for the Care and Use of Laboratory Animals. A standard intraluminal middle cerebral artery method using a 7.0 nylon, silicon-coated monofilament was used to establish a mouse model for focal cerebral ischemia/reperfusion.
14 After a 2-h occlusion, the filament was withdrawn to reperfuse the ischemic brain. Laser Doppler flowmetry was used to monitor cerebral cortical microperfusion to confirm the adequate induction of focal ischemia and successful reperfusion. Blood gases and blood pressure were measured before the induction of ischemia and also in ischemic mice after a 2-h occlusion of the middle cerebral artery. The ischemic brains were examined 22 h after the reperfusion. The brains were excised after transcardial perfusion with icecold phosphate-buffered 4% paraformaldehyde in PBS (pH 7.4). The frozen sections (20 mm thick) were blocked and permeabilized in PBS containing 0.2% Triton-X and 3% normal goat serum, and then incubated overnight at 41C in the presence of appropriately diluted antibodies. The ischemic and contralateral hemispheres were separately homogenized in cell lysis buffer (Cell Signaling Technology) and subjected to western blotting.
